Key Considerations for a US Healthcare IPO
Back Bay Life Science Report · Jonathan P. Gertler, MD and Peter Bak, PhD
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this DNB//Back Bay Healthcare Capital Markets podcast episode, learn about the key considerations, mechanics and timelines of going public on a US exchange.
Topics in this podcast include:
- An overview of the decision-making process through execution for US-based and ex-US healthcare companies thinking about listing in the US
- Core considerations after deciding to pursue a US listing and how to prepare most effectively
- Building the “IPO advisory team”: types of advisors (legal, accounting, banking, IR firms, IP, etc.) and when to bring them in
- Key documents and associated timelines related to the SEC documentation as well as investor outreach
- What are the “don’ts” or mistakes companies make and how to avoid them
You can listen to previous episodes here or submit your inquiries here.
About our guests:
DNB//Back Bay is a committed partner throughout the healthcare development journey, addressing positioning, partnering, financing, M&A strategies, and listing support and execution on US and Nordic exchanges. Our team of more than 100 healthcare strategy and financial specialists spans the globe. Learn more about the DNB//Back Bay Partnership and read our disclaimers at https://www.bblsa.com/dnb-back-bay-partnership.
Cooley is among the top law firms for healthcare, tech and life science IPOs on both the issuer-side and underwriter-side. Their team of 1,300 lawyers is spread across 19 offices worldwide.